Dr James Brooks | Research and Development Manager
BD Biosciences

Dr James Brooks, Research and Development Manager, BD Biosciences

Dr. Brooks received his PhD in Microbiology/Immunology from Wake Forest University where he studied the molecular and cellular aspects of Interleukin-1 signal transduction. He completed post-doctoral training in the laboratory of Nobel Laureate Peter C. Doherty PhD at St Jude Children’s Research Hospital, where he investigated the cellular and molecular mechanisms of viral immunity. Dr. Brooks then joined BD where he has held multiple R&D leadership roles and responsibilities in the areas of inter- and intra-cellular signaling, cell biology/cell culture, and media development. He is currently R&D Manager for BD Advanced Bioprocessing. In this role, he is responsible for global media optimization services and new product and technology development. Combining extensive experience and expertise with innovative tools and technologies, his team is focused on the design and development of high performance cell culture media and supplements to deliver bioprocessing solutions that enhance performance, reduce risk, and increase speed to market.


Day 2 Oct 11th Veterinary @ 10:10

Development of a Serum Free Medium for Expansion of BHK-21 Cells for Vaccine Production

Cell culture media is a critical driver in the biopharmaceutical production process and peptones are frequently used to enhance performance of production media. BHK-21 is an industrially relevant cell line used for production of various animal health vaccines, such as foot-and-mouth disease and rabies. These cells are typically grown in cell culture media supplemented with serum, which introduces additional costs and variability into the process. Understanding the requirements of the animal-health vaccine market, we have leveraged our expertise in peptones and cell culture media development, to develop a high performance serum-free medium for the expansion of BHK-21 cells for vaccine production

back to speakers